The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Christa E. Muller

PharmaCenter Bonn

Pharmaceutical Institute

Pharmaceutical Chemistry I

Pharmaceutical Sciences Bonn (PSB)

Germany

[email]@uni-bonn.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, Pharmaceutical Sciences Bonn (PSB), Germany. 2001 - 2012
  • University of Bonn, Pharmaceutical Institute, An der Immenburg 4, 53121, Germany. 2011
  • University of Bonn, An der Immenburg 4, Germany. 2011
  • Pharmaceutical Institute, Pharmaceutical Sciences Bonn (PSB), University of Bonn, An der Immenburg 4, Germany. 2006
  • Pharmaceutical Institute, University of Bonn, Germany. 2000 - 2003

References

  1. Convergent Synthesis of the Potent P2Y Receptor Antagonist MG 50-3-1 Based on a Regioselective Ullmann Coupling Reaction. Baqi, Y., Müller, C.E. Molecules (2012) [Pubmed]
  2. Xanthines as adenosine receptor antagonists. Müller, C.E., Jacobson, K.A. Handb. Exp. Pharmacol (2011) [Pubmed]
  3. Recent developments in adenosine receptor ligands and their potential as novel drugs. Müller, C.E., Jacobson, K.A. Biochim. Biophys. Acta (2011) [Pubmed]
  4. Prodrug approaches for enhancing the bioavailability of drugs with low solubility. Müller, C.E. Chem. Biodivers. (2009) [Pubmed]
  5. Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Müller, C.E., Iqbal, J., Baqi, Y., Zimmermann, H., Röllich, A., Stephan, H. Bioorg. Med. Chem. Lett. (2006) [Pubmed]
  6. Medicinal chemistry of adenosine A3 receptor ligands. Müller, C.E. Curr. Top. Med. Chem (2003) [Pubmed]
  7. [(3)H]8-Ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one ([(3)H]PSB-11), a novel high-affinity antagonist radioligand for human A(3) adenosine receptors. Müller, C.E., Diekmann, M., Thorand, M., Ozola, V. Bioorg. Med. Chem. Lett. (2002) [Pubmed]
  8. Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists. Müller, C.E., Thorand, M., Qurishi, R., Diekmann, M., Jacobson, K.A., Padgett, W.L., Daly, J.W. J. Med. Chem. (2002) [Pubmed]
  9. Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors. Müller, C.E., Schumacher, B., Brattström, A., Abourashed, E.A., Koetter, U. Life Sci. (2002) [Pubmed]
  10. P2-pyrimidinergic receptors and their ligands. Müller, C.E. Curr. Pharm. Des. (2002) [Pubmed]
  11. A1 adenosine receptors and their ligands: overview and recent developments. Müller, C.E. Farmaco (2001) [Pubmed]
  12. A(3) adenosine receptor antagonists. Müller, C.E. Mini. Rev. Med. Chem (2001) [Pubmed]
  13. Adenosine receptor ligands-recent developments part I. Agonists. Muller, C.E. Curr. Med. Chem. (2000) [Pubmed]
 
WikiGenes - Universities